Stephen Mitchener
Keine laufenden Positionen mehr
Vermögen: 193 753 $ am 31.03.2024
Profil
Stephen Mitchener worked as the Head of US Oncology Strategy, Partnering & Operations at Novartis Pharmaceuticals Corp.
from 2005 to 2018.
He then worked as the Chief Business Officer at Karyopharm Therapeutics, Inc. before becoming the Chief Business Officer & Senior Vice President at Axcella Health, Inc. from 2018 to 2020.
Mitchener holds a doctorate degree from The University of North Carolina at Charlotte.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
01.03.2023 | 128 313 ( 0,11% ) | 193 753 $ | 31.03.2024 |
Ehemalige bekannte Positionen von Stephen Mitchener
Unternehmen | Position | Ende |
---|---|---|
AXCA HEALPAR | Corporate Officer/Principal | 01.12.2020 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01.08.2018 |
KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - |
Ausbildung von Stephen Mitchener
The University of North Carolina at Charlotte | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
KARYOPHARM THERAPEUTICS INC. | Health Technology |
AXCA HEALPAR | Health Technology |
Private Unternehmen | 1 |
---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |